Quotient Sciences Quotient Sciences

X

CAS 127641-25-2 manufacturers and suppliers on PharmaCompass

PharmaCompass
(1R,2S)-N-Pyrrolidinyl-L-Norephedrine Base
Also known as: 127641-25-2, (1r,2s)-1-phenyl-2-(1-pyrrolidinyl)-1-propanol, (1r,2s)-1-phenyl-2-(1-pyrrolidinyl)propan-1-ol, 4r3uv0b3de, Wis9q321lw, (1r,2s)-1-phenyl-2-pyrrolidin-1-yl-propan-1-ol
Molecular Formula
C13H19NO
Molecular Weight
205.30  g/mol
InChI Key
FZVHJGJBJLFWEX-AAEUAGOBSA-N
FDA UNII
WIS9Q321LW

1 2D Structure

(1R,2S)-N-Pyrrolidinyl-L-Norephedrine Base

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1R,2S)-1-phenyl-2-pyrrolidin-1-ylpropan-1-ol
2.1.2 InChI
InChI=1S/C13H19NO/c1-11(14-9-5-6-10-14)13(15)12-7-3-2-4-8-12/h2-4,7-8,11,13,15H,5-6,9-10H2,1H3/t11-,13-/m0/s1
2.1.3 InChI Key
FZVHJGJBJLFWEX-AAEUAGOBSA-N
2.1.4 Canonical SMILES
CC(C(C1=CC=CC=C1)O)N2CCCC2
2.1.5 Isomeric SMILES
C[C@@H]([C@@H](C1=CC=CC=C1)O)N2CCCC2
2.2 Other Identifiers
2.2.1 UNII
WIS9Q321LW
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 127641-25-2

2. (1r,2s)-1-phenyl-2-(1-pyrrolidinyl)-1-propanol

3. (1r,2s)-1-phenyl-2-(1-pyrrolidinyl)propan-1-ol

4. 4r3uv0b3de

5. Wis9q321lw

6. (1r,2s)-1-phenyl-2-pyrrolidin-1-yl-propan-1-ol

7. (1r,2s)-1-phenyl-2-pyrrolidin-1-ylpropan-1-ol

8. 1-phenyl-2-(pyrrolidin-1-yl)propan-1-ol, (1r,2s)-

9. (1r,2s)-2-pyrrolidino-1-phenyl-1-propanol

10. 1-phenyl-2-(pyrrolidin-1-yl)propan-1-ol, Threo-

11. (1r,2s)-(+)-2-(1-pyrrolidyl)-1-phenylpropan-1-ol

12. 1-pyrrolidineethanol, Beta-methyl-alpha-phenyl-, (alphar,betas)-

13. (1r,2s)-n,n-tetramethylenenorephedrine

14. Mfcd01632702

15. Unii-4r3uv0b3de

16. Unii-wis9q321lw

17. Schembl597166

18. Dtxsid60446061

19. (1s,2r)-n-tosylephedrine

20. Zinc5019066

21. Akos015840428

22. Akos015904312

23. Cs-w015370

24. As-68392

25. Threo-dihydro-alpha-pyrrolidinopropiophenone

26. P1374

27. (1r,2s)-1-phenyl-2-pyrrolizino-1-propanol

28. (+)-threo-dihydro-alpha-pyrrolidinopropiophenone

29. A889167

30. J-005517

31. Threo-dihydro-.alpha.-pyrrolidinopropiophenone

32. (+)-threo-dihydro-.alpha.-pyrrolidinopropiophenone

33. (1r,2s)-1-phenyl-2-(1-pyrrolidinyl)-1-propanol, 98%

34. (alphar,betas)-beta-methyl-alpha-phenyl-1-pyrrolidineethanol

35. 1-pyrrolidineethanol, Beta-methyl-alpha-phenyl-, (r*,s*)-(+/-)-

36. 1-pyrrolidineethanol, Beta-methyl-alpha-phenyl-, (r-(r*,s*))-

37. 1-pyrrolidineethanol, Beta-methyl-alpha-phenyl-, (alphar,betas)-rel-

38. (.alpha.r,.beta.s)-.beta.-methyl-.alpha.-phenyl-1-pyrrolidineethanol

39. 1-pyrrolidineethanol, .beta.-methyl-.alpha.-phenyl-, (.alpha.r,.beta.s)-

40. 1-pyrrolidineethanol, .beta.-methyl-.alpha.-phenyl-, (.alpha.r,.beta.s)-rel-

41. 1-pyrrolidineethanol, .beta.-methyl-.alpha.-phenyl-, (r*,s*)-(+/-)-

42. 1-pyrrolidineethanol, .beta.-methyl-.alpha.-phenyl-, (r-(r*,s*))-

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 205.30 g/mol
Molecular Formula C13H19NO
XLogP32
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count3
Exact Mass205.146664230 g/mol
Monoisotopic Mass205.146664230 g/mol
Topological Polar Surface Area23.5 Ų
Heavy Atom Count15
Formal Charge0
Complexity183
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
URL Supplier Web Content
56-91-7
Tranexamic Acid
Established in 2016, a state-of-the-art R&D facility engaged in the development of Novel processes for Bu...
Established in 2016, a state-of-the-art R&D facility engaged in the development of Novel processes for Bulk Actives including Deuterated Actives, Advanced Intermediates and up the value chain. With experience, Anvitha Life Care Private Limited has knowledge and expertise as a leader in chemical research. Every decision is inspired by our main mission, which is to provide the highest standard of product and services to our clients. In this rapidly changing industry, we’ve realized the importance of continually updating our approach to stay relevant in the market, and are committed to just that.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
127641-25-2
Efavirenz
Established in 2016, a state-of-the-art R&D facility engaged in the development of Novel processes for Bu...
Established in 2016, a state-of-the-art R&D facility engaged in the development of Novel processes for Bulk Actives including Deuterated Actives, Advanced Intermediates and up the value chain. With experience, Anvitha Life Care Private Limited has knowledge and expertise as a leader in chemical research. Every decision is inspired by our main mission, which is to provide the highest standard of product and services to our clients. In this rapidly changing industry, we’ve realized the importance of continually updating our approach to stay relevant in the market, and are committed to just that.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
127641-25-2
Embio is today the world’s second largest Integrated manufacturer of Ephedrine and Pseudoephedrine salt...
Embio is today the world’s second largest Integrated manufacturer of Ephedrine and Pseudoephedrine salts Embio’s facility at Mahad ( 180 Kms from Bombay by road ) has been audited and approved by the Australian TGA, and the US FDA Embio has also been granted the Certificate of Suitability ( CoS ) for its Pseudoephedrine HCl
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Taiwan
Digital Content Digital Content
URL Supplier Web Content
127641-25-2
Efavirenz
The company was established in Taiwan in 1987 by the Swiss Siegfried Group with a history of more than 10...
The company was established in Taiwan in 1987 by the Swiss Siegfried Group with a history of more than 100 years. It is engaged in the research and development, production and marketing of intermediates, APIs and specialty chemicals. The products are exported to major pharmaceutical manufacturers in Europe, the United States, and Japan. Affirmed by customers. At present, the main shareholder of the company is the Sanshang Bank Group. The strong shareholder lineup and excellent management team have made the company's performance grow year by year, and it was listed on the Taiwan Stock Exchange in 2004.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY